Metrogel and Malignant neoplasm progression - a phase IV clinical study of FDA data

Summary:

Malignant neoplasm progression is reported as a side effect among people who take Metrogel (metronidazole), especially for people who are female, 60+ old, also take Avastin, and have Pain.

The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Metrogel. It is created by eHealthMe based on reports of 2,715 people who have side effects when taking Metrogel from the FDA, and is updated regularly.

What is Metrogel?

Metrogel has active ingredients of metronidazole. It is often used in rosacea. eHealthMe is studying from 2,819 Metrogel users. Check the latest studies of Metrogel.

What is Malignant neoplasm progression?

Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,510 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.

On Aug, 01, 2026

2,715 people reported to have side effects when taking Metrogel.
Among them, 14 people (0.52%) have Malignant neoplasm progression.

Could Metrogel cause Malignant neoplasm progression?

Among these 14 people:

What is the gender of people who have Malignant neoplasm progression when taking Metrogel? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Malignant neoplasm progression when taking Metrogel? *

What are other drugs people take besides Metrogel? *

What are other side effects people have besides Malignant neoplasm progression? *

Metastases To Bone (cancer spreads to bone): 5 people, 35.71%
Nausea (feeling of having an urge to vomit): 5 people, 35.71%
Abdominal Pain: 5 people, 35.71%
Rashes (redness): 5 people, 35.71%
Joint Pain: 4 people, 28.57%
Nausea And Vomiting: 4 people, 28.57%
Pain: 4 people, 28.57%
Fatigue (feeling of tiredness): 4 people, 28.57%
Metastases To Liver (cancer spreads to liver): 4 people, 28.57%
Arrhythmias (irregular heartbeat): 4 people, 28.57%

What are the existing conditions these people have? *

Pain: 4 people, 28.57%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 3 people, 21.43%
Scrotal Swelling: 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Brain Neoplasm Malignant (brain cancer tumour): 2 people, 14.29%
Metastases To Liver (cancer spreads to liver): 2 people, 14.29%
Metastases To Bone (cancer spreads to bone): 2 people, 14.29%
Gout (uric acid crystals building up in the body): 2 people, 14.29%
Diarrhea: 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Metrogel and have Malignant neoplasm progression?

- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metrogel:

Metrogel (2,819 reports)

Browse all side effects of Metrogel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,510 drugs)

Browse all the conditions that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,636 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metronidazole (the active ingredients of Metrogel) and Metrogel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.